Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex.
暂无分享,去创建一个
[1] Fengqin Gao,et al. Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway. , 2008, Molecular cell.
[2] Y. Pommier,et al. Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. , 2008, Journal of molecular biology.
[3] Jiri Bartek,et al. Human CtIP promotes DNA end resection , 2007, Nature.
[4] Y. Pommier,et al. The Mammalian DNA Replication Elongation Checkpoint: Implication of Chk1 and Relationship with Origin Firing as Determined by Single DNA Molecule and Single Cell Analyses , 2007, Cell cycle.
[5] P. Russell,et al. Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. , 2007, Molecular cell.
[6] K. Sugasawa. Xeroderma pigmentosum genes: functions inside and outside DNA repair. , 2007, Carcinogenesis.
[7] A. Escargueil,et al. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743 , 2007, Proceedings of the National Academy of Sciences.
[8] K. Cimprich,et al. The ATR pathway: fine-tuning the fork. , 2007, DNA repair.
[9] Y. Pommier,et al. Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks , 2007, Molecular Cancer Research.
[10] Y. Pommier,et al. The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses , 2007, Molecular and Cellular Biology.
[11] Y. Pommier,et al. Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks* , 2006, Journal of Biological Chemistry.
[12] S. Moreno,et al. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. , 2006, Cancer research.
[13] Yong-Yeon Cho,et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. , 2006, Molecular cell.
[14] Y. Shiloh. The ATM-mediated DNA-damage response: taking shape. , 2006, Trends in biochemical sciences.
[15] V. Natale,et al. H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] David J. Chen,et al. DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. , 2006, DNA repair.
[17] Jean Gautier,et al. Two-step activation of ATM by DNA and the Mre11–Rad50–Nbs1 complex , 2006, Nature Structural &Molecular Biology.
[18] F. Alt,et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. , 2006, Molecular cell.
[19] M. Yaffe,et al. MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks , 2005, Cell.
[20] J. Blay,et al. ET-743: a novel agent with activity in soft tissue sarcomas. , 2005, The oncologist.
[21] E. Sausville,et al. DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells. , 2005, Cancer research.
[22] Karl-Heinz Krause,et al. BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase , 2005, Oncogene.
[23] Ji-Hoon Lee,et al. ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex , 2005, Science.
[24] Stephen P. Jackson,et al. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.
[25] Y. Pommier,et al. Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. , 2005, Trends in pharmacological sciences.
[26] I. Hardcastle,et al. Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. , 2004, Bioorganic & medicinal chemistry letters.
[27] N. Curtin,et al. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.
[28] H. Tauchi,et al. NBS1 and its functional role in the DNA damage response. , 2004, DNA repair.
[29] A. Sancar,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.
[30] J. Bartek,et al. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation , 2004, Oncogene.
[31] J. Manola,et al. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Weitzman,et al. Structural and functional analysis of Mre11-3. , 2004, Nucleic acids research.
[33] M. D’Incalci,et al. Preclinical and clinical results with the natural marine product ET-743 , 2003, Expert opinion on investigational drugs.
[34] Yair Andegeko,et al. Requirement of the MRN complex for ATM activation by DNA damage , 2003, The EMBO journal.
[35] Y. Pommier,et al. Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.
[36] David A. Boothman,et al. Ku70 suppresses the apoptotic translocation of Bax to mitochondria , 2003, Nature Cell Biology.
[37] M. Kastan,et al. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.
[38] G. Demetri,et al. Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity , 2002, Cancer Chemotherapy and Pharmacology.
[39] M. Weitzman,et al. Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex , 2002, Nature.
[40] Yves Pommier,et al. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action , 2002, Anti-cancer drugs.
[41] P. C. Lee,et al. DNA damage‐induced apoptosis requires the DNA‐dependent protein kinase, and is mediated by the latent population of p53 , 2004 .
[42] K. Scotto,et al. Ecteinascidin-743 inhibits activated but not constitutive transcription. , 2002, Cancer research.
[43] S. Jackson,et al. The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling , 2002, Nature Reviews Molecular Cell Biology.
[44] Michel C. Nussenzweig,et al. Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.
[45] E. Rogakou,et al. Histone H2A variants H2AX and H2AZ. , 2002, Current opinion in genetics & development.
[46] Alessandra Viel,et al. Human MRE11 is inactivated in mismatch repair‐deficient cancers , 2002, EMBO reports.
[47] D. Bearss,et al. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. , 2001, Chemistry & biology.
[48] C. Verschraegen,et al. ET-743 (PharmaMar/NCI/Ortho Biotech). , 2001, Current opinion in investigational drugs.
[49] J. Hoeijmakers,et al. Molecular mechanisms of nucleotide excision repair , 2001 .
[50] Y. Pommier,et al. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair , 2001, Nature Medicine.
[51] R. Hindges,et al. Double‐check probing of DNA bending and unwinding by XPA–RPA: an architectural function in DNA repair , 2001, The EMBO journal.
[52] M. D’Incalci,et al. Unique pattern of ET‐743 activity in different cellular systems with defined deficiencies in DNA‐repair pathways , 2001, International journal of cancer.
[53] B. M. Forman,et al. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.
[54] T. Halazonetis,et al. P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks , 2000, The Journal of cell biology.
[55] R. Mantovani,et al. Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] Y. Pommier,et al. Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff , 2000, Molecular and Cellular Biology.
[57] C. Ling,et al. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] L. Hurley,et al. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. , 1999, Journal of medicinal chemistry.
[59] W. de Laat,et al. Molecular mechanism of nucleotide excision repair. , 1999, Genes & development.
[60] E. Raymond,et al. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[61] W. de Laat,et al. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. , 1998, Genes & development.
[62] M. D’Incalci,et al. Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[63] Yosef Shiloh,et al. Recombinant ATM protein complements the cellular A-T phenotype , 1997, Oncogene.
[64] K. Kohn,et al. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. , 1996, Biochemistry.
[65] R. Sakai,et al. Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the Caribbean tunicate Ecteinascidia turbinata. , 1993, Journal of biomolecular structure & dynamics.
[66] R. Sakai,et al. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[67] Paul A. Keifer,et al. Bioactive Compounds from Aquatic and Terrestrial Sources , 1991 .
[68] J. Petrini,et al. DNA replication-dependent nuclear dynamics of the Mre11 complex. , 2003, Molecular cancer research : MCR.
[69] Y. Pommier,et al. Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[70] M D'Incalci,et al. Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. , 2001, European journal of cancer.